These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24127871)

  • 41. [Skin vaccination].
    Naito S
    Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel laser vaccine adjuvant increases the motility of antigen presenting cells.
    Chen X; Kim P; Farinelli B; Doukas A; Yun SH; Gelfand JA; Anderson RR; Wu MX
    PLoS One; 2010 Oct; 5(10):e13776. PubMed ID: 21048884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [From basic principles to clinical applications on transcutaneous vaccine].
    Okada N
    Yakugaku Zasshi; 2013; 133(12):1363-72. PubMed ID: 24292185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laser adjuvant for vaccination.
    Kashiwagi S
    FASEB J; 2020 Mar; 34(3):3485-3500. PubMed ID: 31994227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Near-infrared laser adjuvant for influenza vaccine.
    Kashiwagi S; Yuan J; Forbes B; Hibert ML; Lee EL; Whicher L; Goudie C; Yang Y; Chen T; Edelblute B; Collette B; Edington L; Trussler J; Nezivar J; Leblanc P; Bronson R; Tsukada K; Suematsu M; Dover J; Brauns T; Gelfand J; Poznansky MC
    PLoS One; 2013; 8(12):e82899. PubMed ID: 24349390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
    Tezel A; Paliwal S; Shen Z; Mitragotri S
    Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous vaccination: antigen delivery into or onto the skin.
    Weniger BG; Glenn GM
    Vaccine; 2013 Jul; 31(34):3389-91. PubMed ID: 23684830
    [No Abstract]   [Full Text] [Related]  

  • 49. Animal models for cutaneous vaccine delivery.
    Hirschberg HJ; van Riet E; Oosterhoff D; Bouwstra JA; Kersten GF
    Eur J Pharm Sci; 2015 Apr; 71():112-22. PubMed ID: 25686596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigens onto bare skin: a 'painless' paradigm shift in vaccine delivery.
    Partidos CD
    Expert Opin Biol Ther; 2003 Sep; 3(6):895-902. PubMed ID: 12943448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy.
    Partidos CD; Muller S
    Cell Mol Life Sci; 2005 Jul; 62(13):1418-24. PubMed ID: 15818468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effective and lesion-free cutaneous influenza vaccination.
    Wang J; Li B; Wu MX
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5005-10. PubMed ID: 25848020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcutaneous antigen delivery system.
    Lee MY; Shin MC; Yang VC
    BMB Rep; 2013 Jan; 46(1):17-24. PubMed ID: 23351379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcutaneous immunization of domestic animals: opportunities and challenges.
    Hammond SA; Tsonis C; Sellins K; Rushlow K; Scharton-Kersten T; Colditz I; Glenn GM
    Adv Drug Deliv Rev; 2000 Sep; 43(1):45-55. PubMed ID: 10967220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcutaneous immunization with influenza vaccines.
    Skountzou I; Kang SM
    Curr Top Microbiol Immunol; 2009; 333():347-68. PubMed ID: 19768414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.
    Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M
    J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
    Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Semiconductor diode laser device adjuvanting intradermal vaccine.
    Kimizuka Y; Callahan JJ; Huang Z; Morse K; Katagiri W; Shigeta A; Bronson R; Takeuchi S; Shimaoka Y; Chan MPK; Zeng Y; Li B; Chen H; Tan RYY; Dwyer C; Mulley T; Leblanc P; Goudie C; Gelfand J; Tsukada K; Brauns T; Poznansky MC; Bean D; Kashiwagi S
    Vaccine; 2017 Apr; 35(18):2404-2412. PubMed ID: 28365253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New Cutaneous Vaccine Adjuvant that STINGs a Little Less.
    Caucheteux SM; Piguet V
    J Invest Dermatol; 2016 Nov; 136(11):2127-2128. PubMed ID: 27772546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.